IMTX: Immatics N.V. Stock

by  •  • Comments Off on IMTX: Immatics N.V. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 499.57
Enterprise Value ($M) n/a
Book Value ($M) 574.84
Book Value / Share 4.73
Price / Book n/a
NCAV ($M) 508.25
NCAV / Share 4.18
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.04

Liquidity (mrq)
Quick Ratio 9.26
Current Ratio 9.26

Balance Sheet (mrq) ($M)
Current Assets 629.55
Assets 696.15
Liabilities 121.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 155.84
Operating Income -38.62
Net Income 15.22

Cash Flow Statement (mra) ($M)
Cash From Operations -158.03
Cash from Investing -152.39
Cash from Financing 319.68

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-07 13G/A T. Rowe Price Investment Management, Inc. 11.60 33.45
02-14 13G/A Rtw Investments, Lp 5.50 -34.59
02-14 13G Vestal Point Capital, LP 5.30
02-14 13G/A Baker Bros. Advisors Lp 6.00 24.61
02-11 13G Suvretta Capital Management, Llc 6.50
11-08 13G/A Wellington Management Group Llp 9.40 52.39
10-17 13D/A Perceptive Advisors Llc 7.90 15.90
06-06 13G/A Arya Sciences Holdings 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 45,911 185,674 24.73
2025-04-16 102,546 345,218 29.70
2025-04-15 137,982 360,939 38.23
2025-04-14 102,940 300,706 34.23

(click for more detail)

Similar Companies
IMMX – Immix Biopharma, Inc. IMNM – Immunome, Inc.
IMNN – Imunon, Inc. INAB – IN8bio, Inc.
INDP – Indaptus Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io